The current status of targeting BAFF/BLyS for autoimmune diseases.
Meera Ramanujam(Boehringer Ingelheim (United States)), Anne Davidson(Feinstein Institute for Medical Research)
Cited by 39
Related Papers
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|11
The immune cell landscape in kidneys of lupus nephritis patients
|bioRxiv (Cold Spring Harbor Laboratory)|2018|8